2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
…, B Combe, KH Costenbader, M Dougados… - Arthritis & …, 2010 - Wiley Online Library
Objective The 1987 American College of Rheumatology (ACR; formerly, the American
Rheumatism Association) classification criteria for rheumatoid arthritis (RA) have been criticized …
Rheumatism Association) classification criteria for rheumatoid arthritis (RA) have been criticized …
The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy
M Dougados, SVD Linden, R Juhlin… - … : Official Journal of …, 1991 - Wiley Online Library
Classification criteria for most of the disorders belonging to the spondylarthropathy group
already exist. However, the spectrum of spondylarthropathy is wider than the sum of these …
already exist. However, the spectrum of spondylarthropathy is wider than the sum of these …
EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for …
…, I Zimmerman-Gorska, M Dougados - Annals of the …, 2003 - ard.bmj.com
Objectives: To update the EULAR recommendations for management of knee osteoarthritis (OA)
by an evidence based medicine and expert opinion approach. Methods: The literature …
by an evidence based medicine and expert opinion approach. Methods: The literature …
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
…, K Chatzidionysiou, M Dougados… - Annals of the …, 2017 - ard.bmj.com
Recent insights in rheumatoid arthritis (RA) necessitated updating the European League
Against Rheumatism (EULAR) RA management recommendations. A large international Task …
Against Rheumatism (EULAR) RA management recommendations. A large international Task …
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
…, M Buch, G Burmester, M Dougados… - Annals of the …, 2014 - ard.bmj.com
In this article, the 2010 European League against Rheumatism (EULAR) recommendations
for the management of rheumatoid arthritis (RA) with synthetic and biological disease-…
for the management of rheumatoid arthritis (RA) with synthetic and biological disease-…
Treating rheumatoid arthritis to target: recommendations of an international task force
Background Aiming at therapeutic targets has reduced the risk of organ failure in many
diseases such as diabetes or hypertension. Such targets have not been defined for rheumatoid …
diseases such as diabetes or hypertension. Such targets have not been defined for rheumatoid …
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
…, JWJ Bijlsma, GR Burmester, M Dougados… - Annals of the …, 2020 - ard.bmj.com
Objectives To provide an update of the European League Against Rheumatism (EULAR)
rheumatoid arthritis (RA) management recommendations to account for the most recent …
rheumatoid arthritis (RA) management recommendations to account for the most recent …
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
…, R Landewé, FC Breedveld, M Dougados… - Annals of the …, 2010 - ard.bmj.com
Treatment of rheumatoid arthritis (RA) may differ among rheumatologists and currently, clear
and consensual international recommendations on RA treatment are not available. In this …
and consensual international recommendations on RA treatment are not available. In this …
Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: results of a multicenter, randomized, double‐blind, placebo‐controlled, phase III trial …
…, P Emery, MW Greenwald, M Dougados… - Arthritis & …, 2006 - Wiley Online Library
Objective To determine the efficacy and safety of treatment with rituximab plus methotrexate
(MTX) in patients with active rheumatoid arthritis (RA) who had an inadequate response to …
(MTX) in patients with active rheumatoid arthritis (RA) who had an inadequate response to …
[PDF][PDF] 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the …
…, C Bombardier, M Dougados… - Arthritis care & …, 2012 - Wiley Online Library
The American College of Rheumatology (ACR) most recently published recommendations
for the use of diseasemodifying antirheumatic drugs (DMARDs) and biologic agents in the …
for the use of diseasemodifying antirheumatic drugs (DMARDs) and biologic agents in the …
Related searches
- maxime dougados eli lilly
- maxime dougados spondyloarthritis
- maxime dougados grant
- maxime dougados dominique baeten
- maxime dougados abbvie
- maxime dougados ucb pharma
- maxime dougados pfizer
- maxime dougados none declared
- maxime dougados lilly and company
- maxime dougados consultant
- maxime dougados novartis
- maxime dougados speakers bureau
- maxime dougados disclosure of interests
- maxime dougados roche
- maxime dougados sanofi